DK1660524T3 - Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdomme - Google Patents
Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdommeInfo
- Publication number
- DK1660524T3 DK1660524T3 DK04780587.4T DK04780587T DK1660524T3 DK 1660524 T3 DK1660524 T3 DK 1660524T3 DK 04780587 T DK04780587 T DK 04780587T DK 1660524 T3 DK1660524 T3 DK 1660524T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- diagnosis
- identification
- monitoring
- periodontal disease
- Prior art date
Links
- 241000605862 Porphyromonas gingivalis Species 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000012544 monitoring process Methods 0.000 title 1
- 208000028169 periodontal disease Diseases 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 230000001018 virulence Effects 0.000 title 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49558903P | 2003-08-15 | 2003-08-15 | |
PCT/US2004/025778 WO2005019249A2 (en) | 2003-08-15 | 2004-08-10 | Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1660524T3 true DK1660524T3 (da) | 2011-05-09 |
Family
ID=36084060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04780587.4T DK1660524T3 (da) | 2003-08-15 | 2004-08-10 | Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdomme |
Country Status (9)
Country | Link |
---|---|
US (2) | US7416852B2 (da) |
EP (2) | EP2426140A1 (da) |
JP (1) | JP2007529195A (da) |
AT (1) | ATE495189T1 (da) |
AU (1) | AU2004266213A1 (da) |
CA (1) | CA2535799A1 (da) |
DE (1) | DE602004031024D1 (da) |
DK (1) | DK1660524T3 (da) |
WO (1) | WO2005019249A2 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
US8129500B2 (en) | 1997-12-10 | 2012-03-06 | Csl Limited | Porphyromonas gingivalis polypeptides and nucleotides |
US7838259B2 (en) * | 2005-02-01 | 2010-11-23 | University Of Florida Research Foundation | Genes of Porphyromonas gingivalis W83 involved in invasion of human cells |
EP2038297A4 (en) | 2006-06-27 | 2010-03-03 | Oral Health Australia Pty Ltd | PORPHYROMONAS GINGIVALIS POLYPEPTIDES SUITABLE FOR PREVENTION OF PERIODONTITIS |
WO2009000066A1 (en) * | 2007-06-22 | 2008-12-31 | University Of Guelph | Vaccine against clostridium perfringens |
US20100297179A1 (en) * | 2007-07-12 | 2010-11-25 | Stuart Geoffrey Dashper | Immunology Treatment for Biofilms |
EP2175851B1 (en) * | 2007-07-12 | 2013-05-15 | Oral Health Australia Pty Ltd | Biofilm treatment |
AU2013203250B2 (en) * | 2007-07-12 | 2014-11-13 | Oral Health Australia Pty Ltd | Immunology treatment for biofilms |
BRPI0917321A2 (pt) * | 2008-08-29 | 2015-11-17 | Oral Health Australia Pty Ltd | prevenção, tratamento e diagnóstico de infecção por p. gingivalis |
US8140041B2 (en) * | 2009-08-27 | 2012-03-20 | Mediatek Inc. | Tunable capacitive device with linearization technique employed therein |
EP2533794A4 (en) * | 2010-02-12 | 2014-04-23 | Univ Sydney | PROTEIN DOMAINS AND ASSOCIATED USES |
MY162557A (en) * | 2010-02-26 | 2017-06-15 | Oral Health Australia Pty Ltd | Treatment or prevention of infection |
TWI542695B (zh) | 2010-12-15 | 2016-07-21 | 日星股份有限公司 | 牙周病原菌血漿或血清抗體價檢查套組 |
WO2012173244A1 (ja) * | 2011-06-17 | 2012-12-20 | 国立大学法人東北大学 | 人獣共通感染性歯周病菌検出用マーカー |
JP6310631B2 (ja) * | 2011-10-18 | 2018-04-11 | サンスター株式会社 | 歯周病原菌血漿または血清抗体価検査キット |
GB201508860D0 (en) | 2015-05-22 | 2015-07-01 | Nat Univ Ireland | Diagnostic method |
WO2020069397A1 (en) * | 2018-09-27 | 2020-04-02 | Cortexyme, Inc. | Methods for detection of microbial nucleic acids in body fluids |
US10487331B1 (en) * | 2018-11-30 | 2019-11-26 | National Cheng Kung University | Aptamers of surface proteins of periodontal pathogens and uses thereof |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4366246A (en) | 1977-11-08 | 1982-12-28 | Genentech, Inc. | Method for microbial polypeptide expression |
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US4474893A (en) | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
US5866136A (en) | 1986-08-01 | 1999-02-02 | Commonwealth Scientific And Industrial Organisation | Recombinant vaccine |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
EP1695978A1 (en) | 1990-06-11 | 2006-08-30 | Gilead Sciences, Inc. | Nucleic acid ligands |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5861254A (en) | 1997-01-31 | 1999-01-19 | Nexstar Pharmaceuticals, Inc. | Flow cell SELEX |
US5840867A (en) | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
US5756291A (en) | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
AR003125A1 (es) | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
US6583275B1 (en) * | 1997-07-02 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics |
US6617156B1 (en) * | 1997-08-15 | 2003-09-09 | Lynn A. Doucette-Stamm | Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics |
EP2264176A1 (en) * | 1997-12-10 | 2010-12-22 | CSL Limited | Porphorymonas gingivalis polypeptides and polynucleotides |
AU1922999A (en) | 1997-12-16 | 1999-07-05 | Baylor College Of Medicine | Needle-free injection of formulated nucleic acid molecules |
US6444799B1 (en) * | 1997-12-31 | 2002-09-03 | Csl Limited | P. gingivalis polynucleotides and uses thereof |
AU6524798A (en) | 1998-03-31 | 1999-10-18 | Dae Woong Pharmaceutical Co., Ltd. | A preventive and therapeutic vaccine for (helicobacter pylori)-associated diseases |
US6180348B1 (en) | 1998-04-20 | 2001-01-30 | Weihua Li | Method of isolating target specific oligonucleotide ligands |
AU750623B2 (en) | 1998-04-22 | 2002-07-25 | Loma Linda University | Methods and substances for preventing and treating autoimmune disease |
MXPA01009073A (es) | 1999-03-10 | 2002-05-06 | Phogen Ltd | Suministro de acidos nucleicos y proteinas a las celulas. |
ATE414172T1 (de) | 1999-08-06 | 2008-11-15 | Oragenics Inc | Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden |
FR2807446B1 (fr) * | 2000-04-11 | 2005-05-06 | Agronomique Inst Nat Rech | Genomes de lactococcus lactis, polypeptides et utilisations |
CZ20024085A3 (cs) * | 2000-06-15 | 2003-05-14 | Smithkline Beecham Corporation | Způsob přípravy fyziologicky aktivního IL-18 polypeptidu |
GB0107658D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
US7060461B2 (en) * | 2002-01-07 | 2006-06-13 | Lifesensors, Inc. | Methods and compositions for protein expression and purification |
-
2004
- 2004-08-10 WO PCT/US2004/025778 patent/WO2005019249A2/en active Application Filing
- 2004-08-10 JP JP2006523285A patent/JP2007529195A/ja active Pending
- 2004-08-10 EP EP10185567A patent/EP2426140A1/en not_active Withdrawn
- 2004-08-10 CA CA002535799A patent/CA2535799A1/en not_active Abandoned
- 2004-08-10 AT AT04780587T patent/ATE495189T1/de not_active IP Right Cessation
- 2004-08-10 US US10/915,002 patent/US7416852B2/en active Active
- 2004-08-10 DK DK04780587.4T patent/DK1660524T3/da active
- 2004-08-10 AU AU2004266213A patent/AU2004266213A1/en not_active Abandoned
- 2004-08-10 EP EP04780587A patent/EP1660524B1/en not_active Not-in-force
- 2004-08-10 DE DE602004031024T patent/DE602004031024D1/de active Active
-
2008
- 2008-07-18 US US12/175,892 patent/US8703436B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP1660524A2 (en) | 2006-05-31 |
JP2007529195A (ja) | 2007-10-25 |
WO2005019249A3 (en) | 2005-09-15 |
US20080299591A1 (en) | 2008-12-04 |
DE602004031024D1 (de) | 2011-02-24 |
WO2005019249A8 (en) | 2005-05-12 |
EP2426140A1 (en) | 2012-03-07 |
US20060078950A1 (en) | 2006-04-13 |
US7416852B2 (en) | 2008-08-26 |
US8703436B2 (en) | 2014-04-22 |
EP1660524B1 (en) | 2011-01-12 |
WO2005019249A2 (en) | 2005-03-03 |
AU2004266213A1 (en) | 2005-03-03 |
ATE495189T1 (de) | 2011-01-15 |
CA2535799A1 (en) | 2005-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1660524T3 (da) | Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdomme | |
ATE365213T1 (de) | Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern | |
DK1530724T3 (da) | Diagnose og forebyggelse af cancercelleinvasion | |
DE602004024542D1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
DK1287364T3 (da) | Diagnostisk og terapi til makulære degenerationsrelaterede lidelser | |
EA201001322A1 (ru) | Вакцины против хламидиоза | |
EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
WO2006059252A3 (en) | Methods and fluorinated compositions for treating amyloid-related diseases | |
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
EA200700708A1 (ru) | Мемантин для лечения расстройств поведения детского возраста | |
NO20062062L (no) | Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat | |
NO20043246L (no) | Nye fremgangsmater til diagnose og behandling av tumorer | |
DE602004003952D1 (de) | Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders | |
ITUD20030118A1 (it) | Dispositivo di sicurezza per macchine operatrici e metodo di riconoscimento della presenza di persone, utilizzante tale dispositivo di sicurezza. | |
NO20055449D0 (no) | Fremgangsmate for diagnostisering av behandling av kreft | |
BR0318042B1 (pt) | aparelho de identificaÇço. | |
NO20053562L (no) | Nye aminobenzofenonforbindelser | |
EA200700878A1 (ru) | Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений | |
DE60331654D1 (de) | Nicht-radioaktives Strontiummittel zur Behandlung von Krebs | |
EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
ITRM20050112U1 (it) | Custodia per la testa di spazzolini da denti. | |
DK1616877T3 (da) | Reagenser til diagnose og terapi af latexallergi og fremgangsmåde til fremstillingen deraf | |
ITMN20030004A1 (it) | Dispositivo di sicurezza per treno diserbatore. | |
ITRM20010087A0 (it) | Metodo per la identificazione di cultivar di olea europaea mediante rapd-pcr. |